Cervical carcinoma (squamous predominant + adeno) · HPV nonavalent vaccination (Gardasil-9) — 3-dose series

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Track	standard
Linked regimen	`REG-HPV-GARDASIL-9`

ID	`IND-CHRONIC-HPV-PREVENTION-VACCINATION-SCREENING`
Type	Indication
Status	reviewed 2026-05-18 \| pending_clinical_signoff
Diseases	`DIS-CERVICAL`
Sources	`SRC-NCCN-ANAL-2025` `SRC-NCCN-CERVICAL-2025`

Notes

STUB — v0.2-A continuation. Vaccine Drug entity (DRUG-GARDASIL-9) needs separate authoring as v0.2-A backlog.

Used By

Contraindications

CI-GARDASIL-9-PREGNANCY - CI-GARDASIL-9-PREGNANCY